Display options
Share it on

Int J Clin Exp Med. 2014 Aug 15;7(8):2329-33. eCollection 2014.

Single nucleotide polymorphisms of DNA mismatch repair genes MSH2 and MLH1 confer susceptibility to esophageal cancer.

International journal of clinical and experimental medicine

Ming-Zhong Sun, Hui-Xiang Ju, Zhong-Wei Zhou, Hao Jin, Rong Zhu

Affiliations

  1. Department of Clinical Laboratory, Affiliated Yancheng Hospital, School of Medicine, Southeast University Yancheng 224001, Jiangsu, China.

PMID: 25232430 PMCID: PMC4161590

Abstract

Defects in DNA mismatch repair genes like MSH2 and MLH1 confer increased risk of cancers. Here, single nucleotide polymorphisms (SNPs) in MSH2 and MLH1 were investigated for their potential contribution to the risk of esophageal cancer. This study recruited 614 participants from Affiliated Yancheng Hospital, School of Medicine, Southeast University, of which 289 were patients with esophageal cancer, and the remainder was healthy individuals who served as a control group. Two SNPs, MSH2 c.2063T>G and MLH1 IVS14-19A>G, were genotyped using PCR-RFLP. Statistical analysis was performed using chi-square test and logistic regression analysis. Carriers of the MSH2 c.2063G allele were at significantly higher risk for esophageal cancer compared to individuals with the TT genotype [OR = 3.36, 95% confidence interval (CI): 1.18-11.03]. The MLH1 IVS14-19A>G allele also conferred significantly increased (1.70-fold) for esophageal cancer compared to the AA genotype (OR = 1.70, 95% CI: 1.13-5.06). Further, the variant alleles interacted such that individuals with the susceptible genotypes at both MSH2 and MLH1 had a significantly exacerbated risk for esophageal cancer (OR = 12.38, 95% CI: 3.09-63.11). In brief, SNPs in the DNA mismatch repair genes MSH2 and MLH1 increase the risk of esophageal cancer. Molecular investigations are needed to uncover the mechanism behind their interaction effect.

Keywords: DNA mismatch repair; Esophageal cancer; MLH1; MSH2; single nucleotide polymorphism

References

  1. Nature. 2012 Jan 18;481(7381):287-94 - PubMed
  2. Carcinogenesis. 2006 Aug;27(8):1670-5 - PubMed
  3. Thorac Surg Clin. 2013 Nov;23(4):509-23 - PubMed
  4. Int J Cancer. 2007 Oct 15;121(8):1643-58 - PubMed
  5. Cancer Lett. 2006 Dec 8;244(2):268-73 - PubMed
  6. Am J Pathol. 2002 Apr;160(4):1481-6 - PubMed
  7. Clin Gastroenterol Hepatol. 2011 Jun;9(6):497-502 - PubMed
  8. Nucleic Acids Res. 2004 Oct 08;32(18):5321-38 - PubMed
  9. PLoS One. 2013 May 31;8(5):e65204 - PubMed
  10. Cancer Cell. 2010 Mar 16;17(3):235-48 - PubMed
  11. Ann Surg Oncol. 2009 Oct;16(10):2918-25 - PubMed
  12. Science. 1994 Aug 19;265(5175):1091-3 - PubMed
  13. Swiss Med Wkly. 2002 Feb 9;132(5-6):57-63 - PubMed
  14. Clin Cancer Res. 2010 Jan 15;16(2):764-74 - PubMed
  15. J Biol Chem. 2012 Nov 30;287(49):41232-44 - PubMed
  16. J Clin Oncol. 2003 Mar 15;21(6):1174-9 - PubMed
  17. Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):541-3 - PubMed

Publication Types